These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4831515)

  • 21. Effects of delta9-THC on food and water intake of deprivation experienced rats.
    Gluck JP; Ferraro DP
    Behav Biol; 1974 Jul; 11(3):395-401. PubMed ID: 4413126
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of tetrahydrocannabinols (delta8-THC and delta9-THC) on body weight, food, and water intake in rats.
    Sjödén PO; Järbe TU; Henriksson BG
    Pharmacol Biochem Behav; 1973; 1(4):395-9. PubMed ID: 4777577
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute effects of two tetrahydrocannabinols (delta9-THC and delta8-THC) on water intake in water deprived rats: implications for behavioral studies on marijuana compounds.
    Järbe TU; Henriksson BG
    Psychopharmacologia; 1973 Jun; 30(4):315-22. PubMed ID: 4722202
    [No Abstract]   [Full Text] [Related]  

  • 24. Incorporation of uridine into ribonucleic acid in rat brain slices after 9 -tetrahydrocannabinol and cannabis.
    Roberge M; Witschi H
    Toxicol Appl Pharmacol; 1972 Nov; 23(3):455-8. PubMed ID: 5085458
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of mescaline, [delta9]-tetrahydrocannabinol and pentobarbital on the auditory evoked responses in the cat.
    Guha D; Pradhan SN
    Neuropharmacology; 1974 Aug; 13(8):755-62. PubMed ID: 4444761
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of oral delta9-tetrahydrocannabinol on operant reinforcement schedule performance in rats.
    Ferraro DP; Gluck JP
    Pharmacology; 1974; 11(2):65-9. PubMed ID: 4829291
    [No Abstract]   [Full Text] [Related]  

  • 27. Acquisition and extinction of variable interval schedule behavior by rats under delta9-tetrahydrocannabinol.
    Ferraro DP; Gluck JP; Herndon GB
    Pharmacol Biochem Behav; 1974; 2(4):487-91. PubMed ID: 4421520
    [No Abstract]   [Full Text] [Related]  

  • 28. Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 9 -tetrahydrocannabinol.
    Gallager DW; Sanders-Bush E; Sulser F
    Psychopharmacologia; 1972; 26(4):337-45. PubMed ID: 4638199
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction of delta9-tetrahydrocannabinol and cannabidiol on intestinal motility in mice.
    Anderson PF; Jackson DM; Chesher GB
    J Pharm Pharmacol; 1974 Feb; 26(2):136-7. PubMed ID: 4150831
    [No Abstract]   [Full Text] [Related]  

  • 30. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
    Taylor DA; Fennessy MR
    Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of delta9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosoma; preparations.
    Howes J; Osgood P
    Neuropharmacology; 1974 Dec; 13(12):1109-14. PubMed ID: 4457762
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of delta9-tetrahydrocannabinol, cannabidiol and cannabinol on ether anaesthesia in mice.
    Malor R; Jackson DM; Chesher GB
    J Pharm Pharmacol; 1975 Aug; 27(8):610-2. PubMed ID: 239179
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of 1 -tetrahydrocannabinol and food deprivation level on responding maintained by the opportunity to attack.
    Cherek DR; Thompson T; Heistad GT
    Physiol Behav; 1972; 9(5):795-800. PubMed ID: 4676261
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of delta9-tetrahydrocannabinol on active avoidance acquisition and passive avoidance retention in rats with amygdaloid lesions.
    Pandina RJ; Musty RE
    Pharmacology; 1975; 13(4):297-308. PubMed ID: 1187754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats.
    Miczek KA; Dixit BN
    Psychopharmacology (Berl); 1980 Feb; 67(2):195-202. PubMed ID: 6245424
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of tetrahydrocannabinols on cyclic AMP levels in rat brain areas.
    Askew WE; Ho BT
    Experientia; 1974 Aug; 30(8):879-80. PubMed ID: 4369974
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
    Rating D; Broermann I; Honecker H; Kluwe S; Coper H
    Psychopharmacologia; 1972; 27(4):349-57. PubMed ID: 4648618
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions of delta9-tetrahydrocannabinol, adrenal steroids, and ethanol.
    List AF; Bartram SF; Nazar BL
    J Pharm Pharmacol; 1975 Aug; 27(8):606-7. PubMed ID: 239177
    [No Abstract]   [Full Text] [Related]  

  • 40. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.